Abstract
Risk factors for hip and knee prosthesis infection have been described, but not psoriasis. Eighty five infected patients from different centers and 202 non infected patients were included in a case-control study. Fifteen of 85 infected patients (17.6%), and 2 of 202 (1%) non infected patients had psoriasis. Odds ratio for infection in patients with psoriasis is 21.4 (4.7-- 195.5), and 39.7 (5.3--1718.8) in patients with hip prosthesis and psoriasis. No significant difference was found in patients with knee prosthesis. These data indicate that psoriasis is a risk factor for hip prostheses infection.
Similar content being viewed by others
References
Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD Jr. Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Jt Surg Am Vol 1982; 64A: 525–535.
Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214–1218.
Brause BD. Infected orthopedic prostheses. In: Bisno AL, Waldvogel FA (eds), Infections associated with indwelling medical devices. Washington DC: American Society for Microbiology 1989: 111–127
Lambert JR, Wright V. Surgery in patients with psoriasis and arthritis. Rheumatol Rehabil 1979; 18: 35–37.
Beyer CA, Hanssen AD, Lewallen DG, Pittelkow MR. Primary total knee arthroplasty in patients with psoriasis. J Bone Jt Surg 1991; 73-B: 258–259.
Menon TJ, Wroblewski BM. Charnley low-friction arthroplasty in patients with psoriasis. Clin Orthop 1983; 176: 127–128.
Stern SH, Insall JN, Windsor RE, Inglis AE, Dines DM. Total knee arthroplasty in patients with psoriasis. Clin Orthop 1989; 248: 108–111.
Rand JA, Fitzgerald RH Jr. Diagnosis and management of the infected total knee arthroplasty. Orthop Clin North Am 1989; 20: 201–210.
Seyral P, Zannier A, Argenson JN, Raoult D. The release of vancomycin and tobramycin from acrylic bone cement in vitro. J Antimicrob Chemother 1994; 33: 337–339.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drancourt, M., Argenson, J.N., Dupont, H.T. et al. Psoriasis is a risk factor for hip-prosthesis infection. Eur J Epidemiol 13, 205–207 (1997). https://doi.org/10.1023/A:1007302330323
Issue Date:
DOI: https://doi.org/10.1023/A:1007302330323